Published in
American Society of Hematology, Blood Advances, 22(3), p. 3674-3687, 2019
DOI: 10.1182/bloodadvances.2018030478
Links
Tools
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML
Journal article published in 2019 by
Bérengère Salomé 
,
M. G. della Porta,
Alejandra Gomez-Cadena,
Romain Loyon,
Madeleine Suffiotti,
Valentina Salvestrini,
Tania Wyss ,
Giulia Vanoni,
Dan Fu Ruan,
Marianna Rossi,
Alessandra Tozzo ,
Paolo Tentorio ,
Elena Bruni,
Carsten Riether ,
Eva-Maria Jacobsen
and other authors.
,
M. G. della Porta,
Alejandra Gomez-Cadena,
Romain Loyon,
Madeleine Suffiotti,
Valentina Salvestrini,
Tania Wyss ,
Giulia Vanoni,
Dan Fu Ruan,
Marianna Rossi,
Alessandra Tozzo ,
Paolo Tentorio ,
Elena Bruni,
Carsten Riether ,
Eva-Maria Jacobsen
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points Human ILC1-like cells kill tumors in a KIR-independent manner. The cytotoxicity of human ILC1-like cells is impaired in AML at diagnosis but is restored in remission.